Literature DB >> 27609904

Differentiation of parathyroid carcinoma and adenoma by preoperative ultrasonography.

Meeyoung Nam1, Han-Seong Jeong2, Jung Hee Shin1.   

Abstract

Background Parathyroid carcinomas (PTC) are very rare. There have been a few studies on the contribution of ultrasound (US) in the diagnosis of PTC compared with parathyroid adenomas (PTA). Purpose To identify the differences between US findings of PTC and PTA in patients with primary hyperparathyroidism (PHPT). Material and Methods We enrolled seven patients with PTC and 32 consecutive patients with PTA whose diagnoses were confirmed by surgery at our institution between March 1994 and June 2015. We retrospectively compared the US features of the two groups, as well as the demographic, clinical, and biochemical characteristics (age, gender, palpability, and serum ionized calcium and parathyroid hormone [PTH] levels). Results The patients with PTC and PTA did not exhibit significant differences in terms of mean age (59.0 years versus 51.1 years; P = 0.2063), sex distribution (male:female, 4:3 versus 1:3; P = 0.1716), mean PTH levels (2855.0 pg/mL versus 1821.5 pg/mL; P = 0.2067), and mean ionized calcium levels (1.7 mMol/L versus 1.5 mMol/L; P = 0.1585) except palpability ( P < 0.0001). On US images, the PTCs were significantly larger (3.5 cm versus 1.9 cm; P = 0.0133) and exhibited higher incidences of heterogeneous echotexture ( P = 0.0002), irregular shape ( P < 0.0001), non-circumscribed margin ( P < 0.0001), intra-nodular calcifications ( P = 0.014), and local invasion ( P = 0.0004) compared to the PTAs. Conclusion In preoperative patients with PHPT, PTCs are differentiated from PTAs by their palpability and significant US features: large size, heterogeneous echotexture, irregular shape, non-circumscribed margin, intra-nodular calcifications, and local invasion.

Entities:  

Keywords:  Parathyroid carcinoma; adenoma; preoperative ultrasonography (US); primary hyperparathyroidism

Mesh:

Year:  2016        PMID: 27609904     DOI: 10.1177/0284185116666418

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  6 in total

Review 1.  Parathyroid Carcinoma: a Review.

Authors:  Shikhar Sawhney; Richa Vaish; Siddhanth Jain; Neha Mittal; Suman Kumar Ankathi; Shivakumar Thiagarajan; Devendra Chaukar
Journal:  Indian J Surg Oncol       Date:  2021-06-03

2.  Parathyroid Carcinoma-An Experience of the Enigma Over 10 Years.

Authors:  Supreet Singh Nayyar; Shivakumar Thiagarajan; Devendra Chaukar; Sarbani Ghosh Laskar; Asawari Patil; Abhishek Mahajan; Snehal Shah
Journal:  Indian J Endocrinol Metab       Date:  2020-04-30

3.  The role of ultrasound in the diagnosis of the coexistence of primary hyperparathyroidism and non-medullary thyroid carcinoma.

Authors:  Jian Shen; Qiong Wu; Yan Wang
Journal:  BMC Med Imaging       Date:  2019-01-18       Impact factor: 1.930

4.  Preoperative inflammatory markers for predicting parathyroid carcinoma.

Authors:  Keiko Ohkuwa; Kiminori Sugino; Ryohei Katoh; Mitsuji Nagahama; Wataru Kitagawa; Kenichi Matsuzu; Akifumi Suzuki; Chisato Tomoda; Kiyomi Hames; Junko Akaishi; Chie Masaki; Kana Yoshioka; Koichi Ito
Journal:  Endocr Connect       Date:  2022-07-14       Impact factor: 3.221

5.  A retrospective review of the role of B-mode and color Doppler ultrasonography in the investigation of primary hyperparathyroidism: Features that differentiate benign from malignant lesions.

Authors:  Cheng Fang; Eleni Konstantatou; Nicola J Mulholland; Serena Baroncini; Mohammad A Husainy; Klaus-Martin Schulte; Paul S Sidhu
Journal:  Ultrasound       Date:  2018-02-10

6.  Primary Hyperparathyroidism in Sickle Cell Disease: An Unknown Complication of the Disease in Adulthood.

Authors:  Elsa Denoix; Charlène Bomahou; Lorraine Clavier; Jean-Antoine Ribeil; François Lionnet; Pablo Bartolucci; Marie Courbebaisse; Jacques Pouchot; Jean-Benoît Arlet
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.